Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation (original ) (raw ) References
Banerjee R and Vonderhaar BK. . 1992 Mol. Cell Endocrinol. 90 : 61–67.
Ben-Jonathan N, Mershon JL, Allen DL and Steinmetz RW. . 1996 Endocr. Rev. 17 : 639–669.
Bole-Feysot C, Goffin V, Edery M, Binart N and Kelly PA. . 1998 Endocr. Rev. 19 : 225–268.
Canbay E, Norman M, Kilic E, Goffin V and Zachary I. . 1997 Biochem. J. 324 : 231–236.
Chen WY, Ramamoorthy P, Chen N, Sticca R and Wagner TE. . 1999 Clin. Cancer Res. 5 : 3583–3593.
Clevenger CV, Chang WP, Ngo W, Pasha TM, Montone KT and Tomaszewski JE. . 1995 Am. J. Pathol. 146 : 695–705.
Clevenger CV and Plank TL. . 1997 J. Mammary Gland. Biol. Neopl. 2 : 59–68.
Dankort DL and Muller WJ. . 2000 Oncogene 19 : 1038–1044.
Das R and Vonderhaar BK. . 1996a Breast Cancer Res. Treatment 40 : 141–149.
Das R and Vonderhaar BK. . 1996b Oncogene 13 : 1139–1145.
Das R and Vonderhaar BK. . 1997 J. Mammary Gland. Biol. Neopl. 2 : 29–39.
DaSilva L, Rui H, Erwin RA, Zack H, Kirken RA, Malabarba MG, Hackett RH, Larner AC and Farrar WL. . 1996 Mol. Cell. Endocrinol. 117 : 131–140.
Dickson C, Creer A and Fantl V. . 2000 Oncogene 19 : 1097–1101.
Ethier SP. . 1995 J. Natl. Cancer Inst. 87 : 964–973.
Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV and Wells JA. . 1992 Science 256 : 1677–1679.
Fuh G, Colosi P, Wood WI and Wells JA. . 1993 J. Biol. Chem. 268 : 5376–5381.
Fuh G and Wells JA. . 1995 J. Biol. Chem. 270 : 13133–13137.
Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP and Jove R. . 1997 Cell Growth Differ. 8 : 1267–1276.
Ginsburg E and Vonderhaar BK. . 1995 Cancer Res. 55 : 2591–2595.
Goffin V, Norman M and Martial JA. . 1992 Mol. Endocrinol. 6 : 1381–1392.
Goffin V, Struman I, Mainfroid V, Kinet S and Martial JA. . 1994 J. Biol. Chem. 269 : 32598–32606.
Goffin V, Shiverick KT, Kelly PA and Martial JA. . 1996a Endocr. Rev. 17 : 385–410.
Goffin V, Kinet S, Ferrag F, Binart N, Martial JA and Kelly PA. . 1996b J. Biol. Chem. 271 : 16573–16579.
Goffin V, Touraine P, Pichard C, Bernichtein S and Kelly PA. . 1999a Mol. Cell. Endocrinol. 151 : 79–87.
Goffin V, Bernichtein S, Carrière O, Bennett WF, Kopchick JJ and Kelly PA. . 1999b Endocrinology 140 : 2853–2856.
Gordon KE, Binas B, Chapman RS, Kurian KM, Clarkson RWE, Clark AJ, Lane EB and Watson CJ. . 2000 Breast Cancer Research 2 : 1–14.
Gouilleux F, Wakao H, Mundt M and Groner B. . 1994 EMBO J. 13 : 4361–4369.
Hankinson SE, Willett WC, Michaud DS, Manson JE, Colditz GA, Longcope C, Rosner B and Speizer FE. . 1999 J. Natl. Cancer Inst. 91 : 629–634.
Horwitz KB. . 1985 Endocrinology 116 : 2236–2245.
Kelly PA, Djiane J, Postel-Vinay MC and Edery M. . 1991 Endocr. Rev. 12 : 235–251.
Kinet S, Bernichtein S, Kelly PA, Martial JJ and Goffin V. . 1999 J. Biol. Chem. 274 : 26033–26043.
Kirken RA, Malabarba MG, Xu J, Liu X, Farrar WL, Hennighausen L, Larner AC, Grimley PM and Rui H. . 1997 J. Biol. Chem. 272 : 14098–14103.
Krumenacker JS, Buckley DJ, Leff MA, McCormack JT, de Jong G, Gout PW, Reed JC, Miyashita T, Magnuson NS and Buckley AR. . 1998 Endocrine 9 : 163–170.
Llovera M, Touraine P, Kelly PA and Goffin V. . 2000 Exper. Gerontol. 35 : 41–51.
Lou W, Ni Z, Dyer K, Tweardy DJ and Gao AC. . 2000 Prostate 42 : 239–242.
Maus MV, Reilly SC and Clevenger CV. . 1999 Endocrinology 140 : 5447–5450.
Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M and Di MV. . 2000 Endocrinology 141 : 118–126.
Nicholson RI, McClelland RA, Robertson JF and Gee JM. . 1999 Endocr. Relat Cancer 6 : 373–387.
Paris N, Rentier-Delrue F, Defontaine A, Goffin V, Lebrun JJ, Mercier L and Martial JA. . 1990 Biotechnol. Appl. Biochem. 12 : 436–449.
Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA and Luttrell LM. . 1999 J. Urol. 162 : 1537–1542.
Saraste A. . 1999 Herz. 24 : 189–195.
Schaber JD, Fang H, Xu J, Grimley PM and Rui H. . 1998 Cancer Res. 58 : 1914–1919.
Shaw-Bruha CM, Pirrucello SJ and Shull JD. . 1997 Breast Cancer Res. Treat. 44 : 243–253.
Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F and Kelly PA. . 1998 J. Clin. Endocrinol. Metab. 83 : 667–674.
Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP and Jove R. . 1998 Mol. Cell Biol. 18 : 2545–2552.
Vomachka AJ, Pratt SL, Lockefeer JA and Horseman ND. . 2000 Oncogene 19 : 1077–1084.
Vonderhaar BK. . 1998 Pharmacol. Ther. 79 : 169–178.
Waters SB and Rillema JA. . 1989 Mol. Cell Endocrinol. 63 : 159–166.
Watson CJ and Miller WR. . 1995 Br. J. Cancer 71 : 840–844.
Wells JA. . 1996 Proc. Natl. Acad. Sci. USA 93 : 1–6.
Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG and Tornell J. . 1997 J. Clin. Invest. 100 : 2744–2751.
Wennbo H and Tornell J. . 2000 Oncogene 19 : 1072–1076.
Wingo PA, Ries LA, Rosenberg HM, Miller DS and Edwards BK. . 1998 Cancer 82 : 1197–1207.
Zhou JN, Ljungdahl S, Shoshan MC, Swedenborg J and Linder S. . 1998 Mol. Carcinog. 21 : 234–243.
Download references